Skip to main content
. Author manuscript; available in PMC: 2017 Sep 21.
Published in final edited form as: Circulation. 2016 Nov 13;135(12):e726–e779. doi: 10.1161/CIR.0000000000000471

Recommendation for ALI Medical Therapy

COR LOE Recommendation

I C-EO In patients with ALI, systemic anticoagulation with heparin should be administered unless contraindicated.

N/A Heparin (generally intravenous unfractionated heparin) is given to all patients acutely.35,364 This can stop thrombus propagation and may provide an anti-inflammatory effect that lessens the ischemia. Patients who have received heparin before the onset of ALI and have a decrease in platelet count may have heparin-induced thrombocytopenia.365,366 In this situation, a direct thrombin inhibitor is given, rather than heparin, if heparin-induced thrombocytopenia with thrombosis is suspected.